Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Akt
    (2)
  • Aurora Kinase
    (2)
  • Bcr-Abl
    (2)
  • FLT
    (2)
  • STAT
    (2)
  • Others
    (2)
TargetMol | Tags By ResearchField
  • Cancer
    (1)
Filter
Search Result
Results for "

cenisertib

" in TargetMol Product Catalog.
  • Inhibitors & Agonists
    3
    TargetMol | All_Pathways
  • Cenisertib
    R-763, AS-703569
    T14925871357-89-0In house
    Cenisertib is A potent ATP-competitive multi-kinase inhibitor, showing inhibitory effects on the activity of Aurora-kinase-A/B, ABL1, AKT, STAT5, FLT3, as well as kinase inhibitors of FER and its homolog. Cenisertib inhibits the growth of tumor mast cells (MCS) by inhibiting the activity of several different molecular targets. Cenisertib also inhibits tumor growth in pancreatic, breast, colon, ovarian and lung cancer and leukemia in xenograft models.
    • $987
    6-8 weeks
    Size
    QTY
  • Cenisertib benzoate
    T713841145859-64-8
    Cenisertib benzoate is an orally bioavailable, synthetic, small-molecule multi-Aurora kinase inhibitor with potential antineoplastic activity.
    • $1,670
    6-8 weeks
    Size
    QTY
  • NB-533
    T713831146544-18-4
    NB-533 is a macrocyclic peptidic BACE-1 inhibitor.
    • $4,520
    10-14 weeks
    Size
    QTY